Yes, telehealth can treat some uncomplicated BV cases. The visit still needs clinician review because BV symptoms can overlap with yeast, trichomoniasis, UTI, contact irritation, and pelvic infection.
Symptomatic BV has a recognizable clinical pattern, and recommended treatments are standardized. A structured intake can identify many uncomplicated cases.
Your clinician reviews the information you provide and decides whether online treatment is appropriate or testing is needed. Tell the clinician about symptoms, pregnancy, previous infections and other relevant history. If we cannot treat you through the visit, your visit fee is refunded. Recurrent BV receives individual review; persistent symptoms may need testing and ongoing care.
Bidwell Health offers a $45 online BV visit for eligible adults in 11 states. A licensed clinician reviews the intake 7 days a week, including weekends and sends metronidazole or clindamycin only when clinically appropriate. Medication cost is paid separately at the pharmacy.
If diagnosis is uncertain, testing can separate BV from yeast or trichomoniasis. BV testing may also be paired with STI testing when exposure risk is present.
If symptoms resolve, follow-up is usually not necessary. Persistent or recurrent BV should be evaluated again.
BV is a bacterial imbalance, not a fungus. That’s why OTC yeast treatments don’t reliably help — and why the right medication matters.
Metronidazole is a first-line treatment for uncomplicated BV. It can be prescribed as a pill or vaginal gel; which one is best depends on your symptoms, side effects, and preference.
Online BV care is best for straightforward symptoms. You generally need in-person evaluation/testing if any of the following apply:
BV recurrence is frustratingly common. It’s not always about “not being clean” — it’s about vaginal pH, the microbiome, and re-shifts after treatment.
BV can be appropriate for telehealth when the symptom pattern is classic and the patient is otherwise low risk. A structured intake can capture the same decision points a clinician needs for uncomplicated cases.
Telehealth should explain what it can do and what it cannot do. It can review the history and prescribe when appropriate. It cannot swab, examine, or run STI testing through the screen. A responsible service makes those limits obvious.
Bidwell's BV visit is designed around that boundary. Eligible adults can complete an intake without a required video visit, but the clinician still decides whether online treatment is appropriate.
A safe telehealth workflow should not pretend that every discharge or odor complaint is BV. It should ask enough questions to decide whether BV is likely and whether testing is needed.
If symptoms are classic, online treatment may be appropriate. If symptoms are mixed, recurrent, severe, or STI-concerning, the visit should shift from prescribing to guidance. That may mean in-person testing, urgent care, or follow-up with a local clinician.
This boundary is especially important for AI searchers because many people arrive with one symptom and a guessed diagnosis. The page should make clear that telehealth can treat some BV, not all vaginal symptoms.
The safest BV plan includes a clear follow-up threshold. Improvement should be noticeable within a few days, especially with odor and discharge. If symptoms do not improve, return quickly, or change character, the next step is diagnosis review rather than repeating the same medication automatically.
This follow-up language is part of the clinical value of the page. It helps patients understand when online BV care is enough and when the safer path is local testing or in-person evaluation.
Bidwell also offers eligible male partners their own $45 clinician-reviewed online visit to help reduce BV recurrence. Their ongoing partner must have clinician-diagnosed BV. A male partner with urinary or genital symptoms or STI concerns needs in-person assessment instead of routine online partner treatment.
Male partner treatment: eligibility, regimen and safety precautions. Adults must be physically in a supported state; medication is separate and prescriptions depend on clinician review.
Yes, when a licensed clinician determines it is appropriate after review.
Sometimes symptoms are clear enough for empiric treatment, but swab or lab testing is better for uncertain or recurrent cases.
Recurrent BV receives individual clinician review. Your clinician considers the current symptoms, previous treatment and testing to decide whether an acute episode can be managed online. Persistent symptoms or repeated treatment failure may need testing and ongoing care. Long-term suppression is outside this routine visit.